BIRTH OF A CANCER DRUG - In 1980, American doctor John Mendelsohn tried to interest someone--anyone--in a treatment he created to stop cancer growth. Twelve years later, he found a believer in ImClone Systems, and then had to watch as the biotech startup struggled to raise development money. Now, after more than 20 years and a constant quest for funding, IMC-C225 looks promising and is awaiting ...
|Year of Publication:||
|Type of Publication:||Article|
|Title record from database:|| OLC-SSG Economic Sciences|
|Availability:||More access options|
|More options (other):|
|Description not available.|